Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 12 - 05 crawled time : 14:00 save search
Medtronic completes enrollment in pivotal trial evaluating first-of-its-kind pulsed field ablation catheter for patients with atrial fibrillation
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
MDT | $80.57 1.37% 0.0% 5M
|
Health Technology
|
| O: -0.73%
H: 0.48%
C: -0.32%
trial
RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
RSPI | $0.0009 0.0% 1.2M
|
Manufacturing
|
| O: 0.0%
H: 52.5%
C: 52.5%
pharmaceuticals stroke collaboration neurological
Cogent Biosciences to Host Investor Webcast to Discuss Updated Clinical Data at ASH from the Ongoing Phase 2 APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
COGT | $7.13 6.26% 5.89% 890K
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: -3.47%
ongoing bezuclastinib trial
First Patients in the World Treated with Impella RP Flex with SmartAssist
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%
|
Health Technology
|
| O: 0.08%
H: 0.36%
C: 0.27%
Dermata Announces Topline Results from DMT310 Phase 2 Clinical Trial for the Treatment of Moderate-to-Severe Rosacea
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
DRMA | $0.3211 -5.36% 38K
|
|
| O: -58.94%
H: 9.51%
C: -2.28%
dmt310 treatment topline trial phase 2
Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
OMCL | News | $28.21 1.37% 1.35% 450K
|
Technology Services
|
| O: -0.61%
H: 0.08%
C: -2.14%
management services
Definitive Healthcare named a 2022 Top Place to Work by The Boston Globe for sixth consecutive year
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
DH | $7.35 4.11% 3.95% 1.1M
|
Professional, Scientific, and T...
|
| O: -1.69%
H: 0.74%
C: 0.08%
work year
Verizon continues to deploy 5G Ultra Wideband faster than expected
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
VZ | News | $38.6 -4.67% 0.1% 50M
|
Communications
|
| O: -0.52%
H: 0.34%
C: -2.4%
expected
Hepion Pharmaceuticals Announces Early Completion of Enrollment in Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
HEPA | $1.45 -27.86% -38.62% 320K
|
Health Technology
|
| O: 1.13%
H: 6.63%
C: -0.88%
pharmaceuticals liver trial phase 2
Financial House Joins LPL Financial
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
XYF | News | $3.875 2.51% 0.65% 6K
|
Finance
|
| O: 1.0%
H: 0.0%
C: -0.43%
LPLA | News | $264.315 0.66% 0.65% 420K
|
Finance
|
| O: -2.0%
H: 0.2%
C: -3.28%
financial house
CCell wins Power System Product of the Year at Elektra Awards
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
VICR | $34.6 2.16% 2.11% 230K
|
Electronic Technology
|
| O: -0.34%
H: 1.05%
C: -1.22%
awards system
GOGL - Transactions made under the buy-back programme
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
GOGL | $13.09 0.93% 0.92% 1M
|
Transportation
|
| O: 4.12%
H: 3.67%
C: -2.68%
Celularity Announces Halal Certification of its Advanced Cellular Therapeutics, Biomaterial Products and Business Model
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
CELU | News F | $3.03 -3.88% 26K
|
|
| O: -1.14%
H: 2.89%
C: -2.31%
certification
Jazz Pharmaceuticals Presents New Findings From Caregiver Survey on Outcomes of Epidiolex® (cannabidiol) for Adult and Pediatric Patients With Severe, Childhood-Onset Epilepsies
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
JAZZ | $108.81 -1.03% -1.04% 510K
|
Health Technology
|
| O: -0.19%
H: 0.0%
C: -3.81%
epidiolex pharmaceuticals
Enlivex Announces Third Quarter 2022 Financial Results and Provides a Business Update
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
ENLV | News | $1.28 -3.03% -3.13% 51K
|
Health Technology
|
| O: 0.0%
H: 1.79%
C: -1.35%
financial update results
iSpecimen Appoints Joseph J. Basile to Board of DirectorsSought-After Strategic Advisor Brings Expertise in Mergers and Acquisitions, Restructuring and Governance to iSpecimen
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
ISPC | $0.339 17.59% 14.96% 1.8M
|
Professional, Scientific, and T...
|
| O: -3.92%
H: 2.72%
C: 1.36%
Arbe to Host Investor and Analyst Meetings at CES 2023
Published: 2022-12-05 (Crawled : 14:00) - globenewswire.com
ARBE | $1.91 3.8% 3.66% 74K
|
|
| O: 1.19%
H: 2.36%
C: -4.13%
ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
NDRA | $0.2464 -0.24% -0.24% 18K
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: -11.3%
sciences life
Jaguar Health Subsidiary Napo Pharmaceuticals Sponsors Episode of The Gayly Dose Focused on HIV-related Diarrhea
Published: 2022-12-05 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1809 15.3% 2.73% 98M
|
Health Technology
|
| O: 1.46%
H: 0.16%
C: -6.97%
pharmaceuticals diarrhea health hiv
Los Angeles Rams and ARound Introduce the Next Generation of Stadium Augmented Reality, Sponsored by SoFi
Published: 2022-12-05 (Crawled : 14:00) - prnewswire.com
STGW F | $5.64 0.89% 0.89% 400K
|
|
| O: -0.8%
H: 2.29%
C: 0.81%
angeles
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.